Evidence map›Paper›PMID 22118808›Full record

Trial reportJournal of psychiatric research2012

Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder.

Boadie W Dunlop, Mary E Kelley, Tanja C Mletzko, Cristina M Velasquez, W Edward Craighead, Helen S Mayberg

Erratum issuedAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of psychiatric research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. The role of depression pharmacogenetic decision support tools in shared decision making.Journal of neural transmission (Vienna, Austria : 1996) · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors.

Boadie W DunlopEmory University School of Medicine, Department of Psychiatry and Behavioral Sciences, 1256 Briarcliff Road NE, Building A, 3rd Floor, Atlanta, GA 30306, USA. bdunlop@emory.edu
Mary E Kelley
Tanja C Mletzko
Cristina M Velasquez
W Edward Craighead
Helen S Mayberg

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Testing an Imaging Biomarker for Treatment Stratification in Major DepressionR01MH073719 · NIMH · EMORY UNIVERSITY · PI DUNLOP, BOADIE W · 2006 to 2018
$5.8M
Neural Correlates of Loss Aversion in Major DepressionK23MH086690 · NIMH · EMORY UNIVERSITY · PI DUNLOP, BOADIE W · 2009 to 2011
$521k
NCATS NIH HHS UL1 TR000454NIMH NIH HHS K23 MH086690NIMH NIH HHS MH073719NIMH NIH HHS R01 MH073719
6 · The paper itself

Abstract

Previous studies suggest that individual preferences for medication- or psychotherapy-based treatments for depression may affect outcomes in clinical trials that compare these two forms of treatment. We assessed patients' beliefs about the causes of their depression, their preferred treatment, and strength of that preference in 80 patients participating in a 12-week clinical trial evaluating neuroimaging predictors of response to cognitive behavior therapy (CBT) or escitalopram. Forty-five patients expressed a preference for one of the 2 treatments, but being matched to preference did not influence remission or completion rates. Medication-preferring patients were more likely to terminate the trial early, regardless of treatment received. CBT-preferring patients rarely endorsed unknown causes for their depression, and medication-preferring patients were highly unlikely to identify pessimistic attitudes as a source of their depression. Among patients willing to be randomized to treatment, preference does not appear to strongly influence outcome. Specific preferences for CBT or medication may reflect differing conceptualizations about depressive illness, knowledge of which may enhance treatment retention and efficacy.

Indexed as

Major Depressive DisorderAdultAntidepressive AgentsCognitive Behavioral TherapyCultureDiagnostic and Statistical Manual of Mental DisordersDouble-Blind MethodFemaleHealth Knowledge, Attitudes, PracticeHumansInterview, PsychologicalMaleMiddle AgedNeuroimagingOutcome and Process Assessment, Health CarePatient DropoutsAntidepressive Agents

Identifiers

PMID22118808
PMCPMC3288535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.